Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07372183 · ClinicalTrials.gov registry record
Wound Healing Following Extraction and Ridge Preservation in Smokers and Non-smokers
A clinical trial, sponsored by Marquette University.
- Not yet
- Registry status
- 12
- Enrollment target
NCT07372183: Clinical Trial study, sponsored by Marquette University.
NCT07372183 is a clinical trial that has not yet begun recruiting, run by Marquette University. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07372183 has not yet begun recruiting, sponsored by Marquette University.
- NOT YET RECRUITING
- Registry status
- 12 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate bone wound healing following extraction and alveolar ridge preservation (bone graft and membrane) clinically, histologically and in relation to gene expression in smokers and non-smokers. Data from a small group of participants will be analyzed after age-matched subjects undergo extraction and alveolar ridge preservation prior to implant placement. The data obtained in this pilot study will be used to plan a full-fledged study involving a larger number of smoking and non-smoking participants to compare the two groups.
Primary Outcome
bone width
Interventions
- OTHER observational study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2026-01-25 |
| Est. Completion | 2028-10-01 |
What is known before NCT07372183 opens enrollment
NCT07372183 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which observational study is the first listed.
NCT07372183 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07372183 about?
NCT07372183 is a clinical study titled "Wound Healing Following Extraction and Ridge Preservation in Smokers and Non-smokers". The goal of this study is to evaluate bone wound healing following extraction and alveolar ridge preservation (bone graft and membrane) clinically, histologically and in relation to gene expression in smokers and non-smokers. Data from a small group of participants will be analyzed after age-matched...
What is the current status of trial NCT07372183?
This trial is currently not yet recruiting. The enrollment target is 12 participants. The study started on 2026-01-25. Estimated completion is 2028-10-01.
What interventions are being tested in trial NCT07372183?
The interventions under investigation include: observational study (OTHER).
Who is sponsoring clinical trial NCT07372183?
This trial is sponsored by Marquette University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI